We found that SZ-A inhibited CD36 and PPARγ mRNA expression and promoted PPARα mRNA expression, suggesting that SZ-A may decrease hepatic lipid accumulation and steatosis by inhibiting de novo lipogenesis and fatty acid uptake, while promoting β-oxidation. This evidence concerns the gene PPARG and steatosis.